Vitamins
- 1047.028
- +12.453+1.20%
Robinhood CEO Says Exchange Is Ready For Roaring Kitty Livestream Surge: 'We Are Prepared' For GameStop Frenzy
Robinhood Markets Inc (NASDAQ:HOOD) is making headlines as CEO Vlad Tenev addresses the company's preparedness for the recent surge in GameStop Corp (NYSE:GME) shares and its strategic acquisition of
The suspected pollution of Erkang Pharmaceuticals' Cambodian factory was evicted due to a local request and an announcement will be made later
Serious pollution
Cai Xukun's “Collapsed House” A Shares Perspective: Yanjing Beer and Tomson Beijian's Endorsements Are Still Top
Traffic entertainers are sometimes a double-edged sword for brands. On June 26, a user with the Weibo account “Ms. C is not too brave” claimed that the traffic artist Cai Xukun had a relationship with a woman, causing her to have an abortion after becoming pregnant, etc., and pointed out that Cai Xukun's mother installed a camera at the woman's doorstep. Cai Xukun has been slow to respond to this. Until the evening of July 2, after CCTV and other platforms removed their videos, Cai Xukun finally responded on the morning of July 3. “There have been a lot of topics about me on the internet recently, so I'm sorry this has taken up everyone's time and attention. I was single two years ago and had a relationship with Ms. C
BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded
Nov 8 (Reuters) - North China Pharmaceutical Co LTd600812.SS :* SAYS UNIT'S ANTI-MONOPOLY CASE HAS BEEN RECINDED BY U.S. COURT IN NEW YORKSource text Further company coverage: 600812.SS (Reporting b
China Resources Sanjiu Logs Higher Net Profit, Revenue in January-September; Shares Slump 10%
03:06 AM EDT, 10/27/2021 (MT Newswires) -- China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) posted a net profit of 1.76 billion yuan ($275.7 million) in the nine months ended Sept. 30
Tianjin Lisheng's Profit Rises in January-September
12:27 AM EDT, 10/25/2021 (MT Newswires) -- Tianjin Lisheng Pharmaceutical (SHE:002393) said its profit attributable to owners jumped to 97.7 million yuan ($15.3 million) in the nine months ended Sept
CSPC Innovation Pharma's Profit, Revenue Rise in Q3
01:48 AM EDT, 10/22/2021 (MT Newswires) -- CSPC Innovation Pharmaceutical's (SHE:300765) net profit for the third quarter ended Sept. 30 rose 4.22% year-over-year to 81 million yuan ($12.7 million),
On September 22nd, 10 companies, including China Nuclear Titanium dioxide and Yongtai Technology, announced positive announcements.
1. Xiamen International Trade: the controlling shareholder intends to increase its stake in the company by 2%. Xiamen International Trade Holdings, the controlling shareholder, increased its stake in the company by means of centralized bidding trading on September 22nd, accounting for 0.07% of the company's issued shares. ITC Holdings and its concerted actors plan to continue to increase their holdings of the company's shares, with a cumulative increase of no less than 5 million shares (including this increase) in the next six months, and no more than 2 per cent of the company's issued shares. The increase plan does not set a price range. two。 Medium nuclear titanium dioxide: the net profit in the first three quarters is expected to increase by 170%, medium nuclear titanium dioxide publishing industry by 220%.
Read Hua Heng Biology 2021 in a picture
According to the Securities Star data Center, Huaheng Biological 2021 reported that the company's main income was 380 million yuan, up 46.88% from the same period last year; the net profit from its parent was 62.1328 million yuan, down 4.11% from the same period last year; deducting 56.1671 million yuan from non-net profit, down 5.47% from the same period last year; debt ratio 19.77%, financial expenses-485200 yuan, gross profit margin 31.77%. There are 10 new shareholders in this period. China Industrial and Commercial Bank of China Co., Ltd.-Yifangda value selection mixed Securities Investment Fund holds 902564 shares, accounting for 3.81% of tradable shares, Ningbo Bank
Sept. 17 Shengda biological limit analysis: vitamin, feed concept hot stock
Securities Star data center news, Shengda biological trading closed, closing price 18.61 yuan. The stock rose by the limit at 10:33 and opened the limit three times. The closing capital was 19.6708 million yuan, accounting for 0.62% of its current market value. In terms of capital flow data, the net inflow of main funds on the same day was 41.6363 million yuan, the net inflow of hot capital was 33.146 million yuan, and the net outflow of retail funds was 22.1671 million yuan. In the past 5 days, the capital flow is shown in the following table: this unit is a vitamin, feed concept hot unit, the same day vitamin concept rose 1.12%, feed concept rose 0.26%. The investment logic of this unit
Sept. 16 Shengda biological limit analysis: feed, vitamin concept hot stock
Securities Star data center news, Shengda biological trading closed, closing price 16.92 yuan. The stock rose by the daily limit at 10:25, but did not open the limit. The closing capital was 38.7706 million yuan, accounting for 1.34% of its current market value. In terms of capital flow data, the net inflow of main funds on the same day was 25.4953 million yuan, the net inflow of hot capital was 27.2923 million yuan, and the net outflow of retail funds was 15.7212 million yuan. In the past 5 days, the capital flow is shown in the following table: this unit is a feed, vitamin concept hot unit, the same day feed concept rose 2.96%, vitamin concept rose 1.74%. The investment logic of this unit
Jizhong Energy: Guotai Junan, Southern Foundation and other two institutions investigated our company on September 13th.
Jizhong Energy (000937) issued a notice on September 15, 2021, saying: Guotai Junan and Southern Fund investigated our company on September 13, 2021, which was received by Zheng Wenya, chief accountant and secretary of the board, and Li Ying on behalf of the company. The main contents of this survey are as follows: 1. What is the profitability of 400000 tons of PVC after it is put into production? A: at present, chemical products such as PVC are in a high operating situation, so the company expects a good profit of 400000 tons of PVC in the future, but the price trend of chemical products has a lot to do with market factors, so it is uncertain whether the price will still be high in the future.
Analysis of the daily limit of Zhenhua shares on September 8: vitamin concept hot stocks
Securities Star data Center News, Zhenhua shares closed by the daily limit of 13.09 yuan. The stock rose by the limit at 14:00, opening the limit once, and the closing capital was 4.6098 million yuan, accounting for 0.08% of its current market value. In terms of capital flow data, the net inflow of main funds on the same day was 12.0323 million yuan, the net inflow of hot capital was 9.4241 million yuan, and the net outflow of retail funds was 17.1515 million yuan. In the past 5 days, the capital flow is shown in the following table: this unit is a hot unit of vitamin concept, which rose 1.52% on the day. The investment logic of the unit is as follows: 1. Global leader in chromium chemicals; 20
On September 3, 10 companies, including Wantai Bio and Yuntu Holdings, announced positive results.
1. Emma Science and Technology: 1 billion yuan is invested in the construction of intelligent electric vehicle and high-speed electric motorcycle project Emma Science and Technology Bulletin intends to set up a project company to invest in the construction of Taizhou intelligent electric vehicle and high-speed electric motorcycle project in Huangyan District of Taizhou City, with a total planned investment of about 1 billion yuan. two。 Metro Holdings: contract sales of 152.291 billion yuan from January to August increased by 9.5% over the same period last year. Metro Holdings announced that the company's cumulative contract sales from January to August were about 152.291 billion yuan, an increase of 9.50% over the same period last year; and the cumulative sales area was about 14.2436 million square meters, an increase of 11% over the same period last year.
Copy homework! These 10 shares are highly sought after by private equity! Which stocks did Feng Liu, Deng Xiaofeng, and Ge Weidong hold more than 60 billion dollars?
As the interim reports came to an end one after another, the latest holdings of many private equity bosses also gradually surfaced. By August 30, 1,633 private equity products had appeared in the list of the top ten tradable shareholders of listed companies. According to public data, with a market capitalization of 54 billion yuan, Gao Yi is far ahead. According to media statistics, Zijin Mining, Sany Heavy Industries, Yonghui Supermarket, Western Superconductor, Tianshan Aluminum, Huayou Cobalt, Wanda Film, Huarui 39, Hengli Hydraulic, and Sunwanda were the 10 largest new private equity markets in the second quarter. Meanwhile, the top ten largest private equity stocks were Maotai, Hikvision, Zijin Mining, and Ziguang Guowei, respectively
Northeast Pharmaceutical: Fangda Iron and Steel and its actors trigger a comprehensive tender offer
On August 23rd, Capital State learned that A-share company Northeast Pharmaceutical (000597.SZ) issued a tender offer report. Fangda Iron and Steel triggered the tender offer by transferring all the shares in Northeast Pharmaceutical held by Dongyao Group and Shengjing Financial Holdings Group. After the completion of this transfer, Fangda Iron and Steel and its actors hold a total of 57.88% of the shares in the company. Fangda Iron and Steel issued a comprehensive offer to shareholders other than Northeast Pharmaceutical, except Fang Daosteel and its concerted actors, Dongyao Group and Shengjing Financial Control Group, with an offer price of 4.93 yuan per share. This offer is not intended to terminate the listing status of Northeast Pharmaceutical.
CSPC Innovation Halts Trading on Major Asset Purchase Plan
07:26 PM EDT, 07/13/2021 (MT Newswires) -- Shares of CSPC Innovation Pharmaceutical (SHE:300765) have been suspended from trading since Tuesday as the company plans to carry out a major asset purchas
On July 13, 12 companies, including Guangji Pharmaceutical Co., Ltd., Jingdong Jingdian Co., Ltd., showed positive announcements.
1. Run Bang shares: it is expected that the net profit in the first half of the year will increase by 161.22% ~ 188.71% compared with the same period last year. Runbang Co., Ltd. is expected to make a profit of 190 million yuan to 210 million yuan in the first half, an increase of 161.22% ~ 188.71% over the same period last year. This is mainly due to the large growth of the company's high-end equipment business and environmental protection business as a whole during the reporting period. two。 Jingdong Jingdian: it is expected that the profit attributable to shareholders in the first half of the year will increase by not less than 400% compared with the same period last year, BOE Jingdian announced on the Hong Kong Stock Exchange that the profit attributable to shareholders in the first half of the year is expected to increase by not less than 400% compared with the same period last year, mainly due to the sales
Jiangxi Fangda Steel to Raise Stake in Northeast Pharma to 58% For $418 Million, Triggering Tender Offer
07:41 PM EDT, 07/05/2021 (MT Newswires) -- Jiangxi Fangda Steel Group has agreed to raise its stake in Northeast Pharmaceutical Group (SHE:000597) to 57.88% from 38.97% in a deal worth 2.7 billion yu
Fangda Iron and Steel plans to transfer 18.91% of Northeast Pharmaceutical shares for 1.251 billion yuan.
On July 5, Capital learned that Northeast Pharmaceutical (000597.SZ), an A-share company, had received a report on the offer. This offer is triggered by Fang Da Steel's transfer to Northeast Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Dongyao Group") and Shenyang Shengjing Financial Investment Group Co., Ltd. (hereinafter referred to as "Shengjing Financial Control Group"). Triggered by all the shares held by Northeast Pharmaceutical. The company received notification from Dongyao Group and its concerted actor, Shengjing Financial Control Group, that Dongyao Group and Shengjing Financial Control Group had signed a share transfer agreement with Fangda Iron and Steel on July 4. According to the agreement, Dongyao Group and Shengjingjin